|
ZNF524 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.59740000005293E-06 |
| Normal-vs-Stage3 |
1.63424829224823E-12 |
| Normal-vs-Stage4 |
1.66122671174662E-12 |
| Stage1-vs-Stage2 |
7.692600E-01 |
| Stage1-vs-Stage3 |
3.264200E-01 |
| Stage1-vs-Stage4 |
1.977840E-01 |
| Stage2-vs-Stage3 |
3.808800E-01 |
| Stage2-vs-Stage4 |
2.610600E-01 |
| Stage3-vs-Stage4 |
7.180800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.07550000000434E-05 |
| Normal-vs-Asian |
3.18659987286196E-10 |
| Caucasian-vs-AfricanAmerican |
5.455600E-01 |
| Caucasian-vs-Asian |
3.828600E-01 |
| AfricanAmerican-vs-Asian |
2.911800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.693000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.36199940214965E-11 |
| Normal-vs-Age(81-100Yrs) |
9.921500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.183000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.615600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.790400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.822200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.378400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.001600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.929800E-01 |
| Classical-VS-Follicular |
2.849600E-01 |
| Classical-VS-Other |
9.769000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.383000E-01 |
| Tall-VS-Other |
9.808000E-01 |
| Tall-VS-Normal |
4.13049999981041E-07 |
| Follicular-VS-Other |
7.121800E-01 |
| Follicular-VS-Normal |
1.56149981833664E-10 |
| Other-VS-Normal |
1.97608999999987E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.07549524841488E-11 |
| N0-vs-N1 |
8.607700E-02 |
|
|
